Post Type Archives: News

Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), has become a signatory of the United Nations Global Compact (UNGC), the largest global voluntary sustainability and social responsibility initiative. With this development, Bespak now officially joins the collaborative UNGC network of over 20,000 companies and 3,800 non-business entities working to enact meaningful change. Bespak […]

Sunresin New Materials Co., Ltd. is proud to announce the creation of Sunresin EU, a new European subsidiary based in Uppsala, Sweden — the historic heart of chromatography and a major life sciences innovation hub. This strategic expansion marks a significant step in Sunresin’s global growth, strengthening its presence in Europe and reinforcing its commitment […]

More than 260 expert speakers confirmed, and introducing the Leadership Summit, a platform bringing together pharma leaders to drive industry change  voices Informa Markets, the team behind CPHI Frankfurt has unveiled its 2025 speaker line-up, featuring an inspiring agenda of global pharma leaders, innovators, and changemakers. With a brand-new Leadership Summit debuting at this year’s […]

Dianthus Therapeutics, a clinical-stage biotechnology company developing treatments for autoimmune diseases, announced an exclusive licensing agreement with Nanjing Leads Biolabs for DNTH212 on October 16th. According to a company press release, Dianthus will pay Leads $38 million upfront, with total compensation of up to $1 billion tied to the completion of various development and regulatory […]

Shenzhen Pregen Biopharma announced a license and collaboration agreement with Kite Pharma, a Gilead company, to support the research and development of next-generation in vivo therapies. Kite will pay Pregene $120 million upfront and provide additional compensation of up to $1.52 billion upon completion of undisclosed milestones, as well as royalties based on the net […]

Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, today announced the close of a £5M pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, Wilbe, and Angel investors. The investment will enable Cyclana Bio to develop functional disease models and its platform, dedicated to revolutionising women’s health through […]

giles AI, a company making advanced research tools accessible to all and simplifying how scientists work with data, has announced the commercial launch of giles, its AI specialised research agent designed to support healthcare, clinical, and medical research. By extracting, analysing, summarising, and referencing information from verified medical databases and private files, giles enables rapid […]

Mosaic Therapeutics, Ltd, an oncology therapeutics company building the category leader in Synergistic Precision Oncology, announced the appointment of Thomas Fuchs as CEO. Thomas will lead the Company to advance its pipeline of proprietary drug combination programmes into the clinic, and through a planned Series B financing round. Mosaic is applying its advanced experimental and […]

ACG, the world’s most integrated provider of solid-dosage solutions, today announced a $200 million phased investment to establish its first empty-capsule manufacturing operations in the United States. The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta, Georgia, with a second phase of $100 million planned to expand capacity and capabilities in the region. The investment is expected to create more […]

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins has announced plans for further expansion, reinforcing its position as a strategic partner for biopharmaceutical companies developing next-generation therapies. For 25 years, ABT has worked alongside biotech and pharma companies to provide scalable and reproducible chromatography solutions that are critical to the development and […]